ASHIKA STOCK INTELLIGENCE • NSE : SUNPHARMA • BSE : 527471
Sun Pharmaceutical
Share Price
₹1690.20▼ 0.76% today
52-wk low ₹1,64652-WEEK RANGE52-wk high ₹1,731
₹1,690.2 sits in the upper half of its 52-week range · day range ₹1,668 – ₹1,702
Live · 25 Sept 2025, 13:53 IST
Get Started Today!
SUNPHARMA trades at 22.3× PE vs sector 24.2x. Promoter holding 0.0% - FY profit +9% YoY.
- Valuation Read8%Discount to sector PE
- Institutional Base67.2%7.1% FII-14.3% MF
- Balance Sheet0.00xDebt to equity cover 71.3x
- Trend checkBelow 200-DMALong-term trend still weak
FUNDAMENTALS
Key Statistics, Valuation, Returns and Leverage
VALUATION65/100
22.3× PESector PE 24.2x-lower score means richer valuation
GROWTH58/100
+9% YoYFY profit growth vs sector median 11%
QUALITY72/100
17.5% ROEDebt-free, interest cover 71.3x
Market Cap₹12.0k CrMid cap
P/E (TTM)22.3×Sector 24.2×
P/B3.22×Book value ₹291
EPS (TTM)₹42.0Per share
ROE17.5%Return on equity
ROCE15.6%Capital efficiency
Dividend Yield4.27%Latest ₹26 / share
Debt / Equity0.00×Debt-free
EV / EBITDA11.7×Enterprise value
PEG Ratio2.52Growth-adjusted
Book Value₹291Per share
Face Value₹10Per share
Share price & trading details
Open₹1690.2
Previous Close₹1703.05
Day High₹1702
Day Low₹1668
Volume7,698
52-Wk High₹1731
52-Wk Low₹1646
VWAP₹1687
Upper Circuit₹1851
Lower Circuit₹1516
PERFORMANCE
Investment Returns
9.98%Over 1 Month
9.98%Over 3 Month
9.98%Over 6 Month
9.98%Over 1 Year
SUNPHARMA price vs 200-day average
12 Mar 2026 Price 200-DMA09 Jul 2026
Range high ₹2,019Range low ₹1,452Return -18.6%
SIP CALCULATOR
Return Estimator
Estimation is based on the past performance
₹
%
Investment Amount₹5,76,000Est Returns₹7,13,009
The Value of Your Investment after 12 Years will be₹12,89,009Start Investing
FINANCIALS
Sun Pharmaceutical Financials
80K60K40K20K0
Dec 2023Mar 2024Jul 2024Oct 2024Dec 2024Mar 2025
All Value are in CrRevenueEBITDANet Profit
| Quarterly Statement | Dec 2023 | Mar 2024 | Jul 2024 | Oct 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Revenue | 62,400 | 70,200 | 66,950 | 65,000 | 63,050 | 63,700 |
| Expenses | 40,740 | 39,900 | 43,680 | 43,260 | 44,940 | 39,060 |
| EBITDA | 21,160 | 23,000 | 25,070 | 23,690 | 21,160 | 24,840 |
| Operating Profit | 19,530 | 21,000 | 21,840 | 19,320 | 20,370 | 22,680 |
| Operating Profit Margin % | 31 | 34 | 29 | 35 | 32 | 35 |
| Other Income | 1,818 | 1,692 | 1,980 | 1,908 | 1,782 | 1,872 |
| Interest | 297 | 282 | 321 | 285 | 273 | 312 |
| Depreciation | 954 | 891 | 927 | 873 | 918 | 882 |
| Profit Before Tax | 19,656 | 21,816 | 21,168 | 23,544 | 20,304 | 21,600 |
| Tax % | 23 | 26 | 27 | 23 | 23 | 28 |
| Net Profit | 14,742 | 16,524 | 15,552 | 16,848 | 15,552 | 16,200 |
| EPS | 43 | 41 | 41 | 43 | 42 | 44 |
Shareholding pattern
- 7.06%Promoter
- 10.15%FII
- 17.18%Mutual Fund
- 23.06%Insurance/other
- 46.57%Public
0.00% Promoter Shares Pledged-Effectively Zero.
FII VS DII Trend
Foreign vs Domestic Institutional holding over recent quarters.
1209060300
Q1Q2Q3Q4
TECHNICALS
Moving averages, delivery & derivatives
EMA & SMA
Current Price₹1,690 -12.85(-0.76%)
Bearish Moving Average 34Bullish Moving Average 6
EMA
5-EMA1740.91
10-EMA1724.00
20-EMA1707.10
50-EMA1673.30
100-EMA1690.20
200-EMA1740.91
SMA
5-SMA1656.40
10-SMA1690.20
20-SMA1690.20
50-SMA1724.00
100-SMA1690.20
200-SMA1673.30
Delivery & Volume
DAYWEEKMONTH
0L10L20L30L40L50L60L70L
Combined Delivery VolumeNSE+BSE Traded Volume
SUNPHARMA F&O
Derivatives positioning — Put-Call Ratio and open interest (current expiry).
This stock is not in the F&O segment, or derivatives data is unavailable.
SWOT Analysis
Auto-generated from the company's own fundamentals (not advice).
Strengths
- Low leverage (D/E 0.00)
- Comfortable interest cover (71.3x)
- Negligible promoter pledge
- Healthy ROE (17.5%)
Weaknesses
- Trading below 200-DMA
- Promoter holding 0.0%
- PEG above 2 (2.52)
- Revenue growth trailing sector
Opportunities
- Rising SIP inflows industry-wide
- PMS and AIF expansion
- Offshore mandates
- Retirement solutions (NPS) growth
Threats
- Fee compression from passive funds
- Regulatory changes to TER
- Market-linked AUM volatility
- Competition from fintech distributors
CORPORATE ACTIONS
Dividends & what's coming up
Latest Dividend (Final)₹26 / share260% of face value · record date 23 Jan 2025
Upcoming — Board Meeting22 July 2026Sun Pharmaceutical has informed BSE that a meeting of the Board of Directors is scheduled — quarterly results on the agenda.
Payout History
2025-04-29 · Final₹26
2024-04-29 · Final₹22
Yield at current price: 4.27%About SUNPHARMA
Sun Pharmaceutical is a publicly traded company in the Pharmaceuticals sector listed on NSE and BSE.
IndustryPharmaceuticals
Incorporated:2002
Chairman:—
Auditor:BSR & Co LLP
SUNPHARMA Peer Comparison
Greener = more attractive on that metric. SUNPHARMA highlighted.
| Company | Price | P/E | P/B | ROE % | DIV % | OPM % | NPM % |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical | ₹1,690 | 22.3 | 3.2 | 17.5 | 4.3 | 48.3 | 39.8 |
| HDFC AMC | ₹4,210 | 38.1 | 12.4 | 29.8 | 1.7 | 76.2 | 61.5 |
| Nippon Life India AMC | ₹720 | 31.6 | 10.9 | 30.2 | 2.4 | 63.7 | 54.1 |
| Aditya Birla Sun Life AMC | ₹780 | 25.4 | 6.8 | 27.1 | 2.9 | 61.3 | 52.8 |
INVEST
Four simple steps to own SUNPHARMA
- 1Open a demat account
- 2Add funds
- 3Search SUNPHARMA
- 4Place your order
The Future Of Investing Is Here!
Open demat & trading account in 10 mins
FAQ
Frequently Asked Questions
Can I buy Sun Pharmaceutical (SUNPHARMA) from Ashika?
Yes, You can buy Sun Pharmaceutical (SUNPHARMA) shares by opening a Demat account with Ashika.
How do I buy Sun Pharmaceutical (SUNPHARMA) from Ashika?
Sun Pharmaceutical (SUNPHARMA) share can be bought through the following modes:
1. Direct investment: You can buy Sun Pharmaceutical (SUNPHARMA) shares by opening a Demat account with Ashika.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Sun Pharmaceutical (SUNPHARMA) shares.
What is the main business of Sun Pharmaceutical (SUNPHARMA)?
Sun Pharmaceutical operates in the Pharmaceuticals sector.
Who are the promoters of Sun Pharmaceutical (SUNPHARMA)?
Promoter details are published in the company's latest shareholding disclosure to the exchanges.
What are the Subsidiaries that comes under Sun Pharmaceutical (SUNPHARMA)?
Subsidiaries are listed in the company's latest annual report.